Press releases

The goal of the conference is to establish new contacts and identify business and collaboration opportunities. The conference will gather early stage and...
On August 27, Lipums CEO Einar Pontén will present our recent progress towards a novel treatment of chronic inflammatory diseases. The presentation...
Read the article from Biostock here ►
Abzena, the global biologics gene to GMP partner research organization, announced it has signed an agreement to support an integrated CMC program with...
Lipum has identified the novel target molecule Bile Salt-Stimulated Lipase (BSSL). Preclinical studies have very successfully verified the concept in several...

Investor relations